Aesthetic practices across the U.S. are reporting a surge in demand for combination treatments targeting "Ozempic face"—the hollowed, aged appearance caused by rapid weight loss from GLP-1 receptor agonists. Practices are bundling Botox or Dysport with volumizing fillers, biostimulators, and facial treatments to address dynamic lines, structural volume loss, and skin quality simultaneously.